Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07032129
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:40.068033+00:00
Published At
2025-06-22T00:00:00+00:00
Record Updated At
2025-06-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Multiple Myeloma", "Multiple Myeloma in Relapse", "Multiple Myeloma Progression", "Multiple Myeloma, Refractory"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-06-22"
protocolSection.identificationModule.nctId
"NCT07032129"
protocolSection.identificationModule.officialTitle
"Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Multiple Myeloma (protocolSection.conditionsModule.conditions)
  • Multiple Myeloma in Relapse (protocolSection.conditionsModule.conditions)
  • Multiple Myeloma Progression (protocolSection.conditionsModule.conditions)
  • Multiple Myeloma, Refractory (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.